Cargando…
SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer
BACKGROUND: We investigated the relationship of the polymorphisms of SET and MYND domain-containing protein 3 (SMYD3) with risk and prognosis of ovarian cancer. MATERIAL/METHODS: The polymerase chain reaction (PCR) amplification method was applied to detect the polymorphisms of variable number of ta...
Autores principales: | Liu, Ting-Ting, Xu, Hui, Gao, Wei-Ping, Zhang, Shu-Xiang, Zhou, Xu-Hong, Tang, Juan, Liu, Qiong-Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207010/ https://www.ncbi.nlm.nih.gov/pubmed/28024138 http://dx.doi.org/10.12659/MSM.898095 |
Ejemplares similares
-
Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma
por: Xu, Wenchao, et al.
Publicado: (2018) -
Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?
por: Zhang, Yingxue, et al.
Publicado: (2019) -
Structure and Function of SET and MYND Domain-Containing Proteins
por: Spellmon, Nicholas, et al.
Publicado: (2015) -
SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin
por: Wang, Lei, et al.
Publicado: (2020) -
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
por: Brown, Mark A, et al.
Publicado: (2006)